199 related articles for article (PubMed ID: 36761762)
1. Human antibodies targeting ENPP1 as candidate therapeutics for cancers.
Chu X; Baek DS; Li W; Shyp T; Mooney B; Hines MG; Morin GB; Sorensen PH; Dimitrov DS
Front Immunol; 2023; 14():1070492. PubMed ID: 36761762
[TBL] [Abstract][Full Text] [Related]
2. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.
Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H
J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342
[TBL] [Abstract][Full Text] [Related]
3. Human Antibody V
Chu X; Li W; Hines MG; Lyakhov I; Mellors JW; Dimitrov DS
Mol Pharm; 2023 May; 20(5):2754-2760. PubMed ID: 37067377
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1.
Abbasi S; Shin DM; Beaty N; Masiuk M; Chen S; Gonzalez-Garcia I; Zhao M; Goding J; Morse HC; Wang H
Hybridoma (Larchmt); 2011 Feb; 30(1):11-7. PubMed ID: 21466281
[TBL] [Abstract][Full Text] [Related]
5. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852
[TBL] [Abstract][Full Text] [Related]
6. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.
Ruiz-Fernández de Córdoba B; Moreno H; Valencia K; Perurena N; Ruedas P; Walle T; Pezonaga-Torres A; Hinojosa J; Guruceaga E; Pineda-Lucena A; Abengózar-Muela M; Cochonneau D; Zandueta C; Martínez-Canarias S; Teijeira Á; Ajona D; Ortiz-Espinosa S; Morales X; Ortiz de Solórzano C; Santisteban M; Ramos-García LI; Guembe L; Strnad V; Heymann D; Hervás-Stubbs S; Pío R; Rodríguez-Ruiz ME; de Andrea CE; Vicent S; Melero I; Lecanda F; Martínez-Monge R
Cancer Discov; 2022 May; 12(5):1356-1377. PubMed ID: 35191482
[TBL] [Abstract][Full Text] [Related]
7. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy.
Wang X; Lu X; Yan D; Zhou Y; Tan X
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806118
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation.
Nam HK; Liu J; Li Y; Kragor A; Hatch NE
J Biol Chem; 2011 Nov; 286(45):39059-71. PubMed ID: 21930712
[TBL] [Abstract][Full Text] [Related]
9. ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1.
Onyedibe KI; Wang M; Sintim HO
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752288
[TBL] [Abstract][Full Text] [Related]
10. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
Wang H; Ye F; Zhou C; Cheng Q; Chen H
PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867
[TBL] [Abstract][Full Text] [Related]
11. Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.
Takahashi RU; Miyazaki H; Takeshita F; Yamamoto Y; Minoura K; Ono M; Kodaira M; Tamura K; Mori M; Ochiya T
Nat Commun; 2015 Jun; 6():7318. PubMed ID: 26065921
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Pyrido[2,3-
Sun Y; Chen M; Han Y; Li W; Ma X; Shi Z; Zhou Y; Xu L; Yu L; Wang Y; Yu J; Diao X; Meng L; Xu S
J Med Chem; 2024 Mar; 67(5):3986-4006. PubMed ID: 38387074
[TBL] [Abstract][Full Text] [Related]
13. Effects of Different Variants in the ENPP1 Gene on the Functional Properties of Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1.
Stella J; Buers I; van de Wetering K; Höhne W; Rutsch F; Nitschke Y
Hum Mutat; 2016 Nov; 37(11):1190-1201. PubMed ID: 27467858
[TBL] [Abstract][Full Text] [Related]
14. Metabolic consequences of ENPP1 overexpression in adipose tissue.
Pan W; Ciociola E; Saraf M; Tumurbaatar B; Tuvdendorj D; Prasad S; Chandalia M; Abate N
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E901-11. PubMed ID: 21810932
[TBL] [Abstract][Full Text] [Related]
15. The role of ENPP1/PC-1 in osteoinduction by calcium phosphate ceramics.
Othman Z; Fernandes H; Groot AJ; Luider TM; Alcinesio A; Pereira DM; Guttenplan APM; Yuan H; Habibovic P
Biomaterials; 2019 Jul; 210():12-24. PubMed ID: 31048198
[TBL] [Abstract][Full Text] [Related]
16. HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer.
Attalla SS; Boucher J; Proud H; Taifour T; Zuo D; Sanguin-Gendreau V; Ling C; Johnson G; Li V; Luo RB; Kuasne H; Papavasiliou V; Walsh LA; Barok M; Joensuu H; Park M; Roux PP; Muller WJ
Cancer Immunol Res; 2023 Sep; 11(9):1184-1202. PubMed ID: 37311021
[TBL] [Abstract][Full Text] [Related]
17. Enpp1: a potential facilitator of breast cancer bone metastasis.
Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL
PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1.
Chandalia M; Davila H; Pan W; Szuszkiewicz M; Tuvdendorj D; Livingston EH; Abate N
J Clin Endocrinol Metab; 2012 Dec; 97(12):4663-72. PubMed ID: 23012391
[TBL] [Abstract][Full Text] [Related]
19. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects.
Guan D; Fang L; Feng M; Guo S; Xie L; Chen C; Sun X; Wu Q; Yuan X; Xie Z; Zhou J; Zhang H
Eur J Med Chem; 2024 Mar; 267():116211. PubMed ID: 38359537
[TBL] [Abstract][Full Text] [Related]
20. AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.
Doñate F; Raitano A; Morrison K; An Z; Capo L; Aviña H; Karki S; Morrison K; Yang P; Ou J; Moriya R; Shostak Y; Malik F; Nadell R; Liu W; Satpayev D; Atkinson J; Joseph IB; Pereira DS; Challita-Eid PM; Stover DR
Clin Cancer Res; 2016 Apr; 22(8):1989-99. PubMed ID: 26589436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]